Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Oleanolic Acid Modulates DNA Damage Response to Camptothecin Increasing Cancer Cell Death.
Mazzarotti G, Cuomo M, Ragosta MC, Russo A, D'Angelo M, Medugno A, Napolitano GM, Iannuzzi CA, Forte IM, Camerlingo R, Burk S, Errichiello F, Frusciante L, Forino M, Campitiello MR, De Laurentiis M, Giordano A, Alfano L. Mazzarotti G, et al. Among authors: camerlingo r. Int J Mol Sci. 2024 Dec 16;25(24):13475. doi: 10.3390/ijms252413475. Int J Mol Sci. 2024. PMID: 39769237 Free PMC article.
CXCL12-loaded-hydrogel (CLG): A new device for metastatic circulating tumor cells (CTCs) capturing and characterization.
Portella L, Bertolini G, Guardascione G, Di Febbraro DG, Ieranò C, D'Alterio C, Rea G, Napolitano M, Santagata S, Trotta AM, Camerlingo R, Scarpa E, Cecere SC, Ottaiano A, Palumbo G, Morabito A, Somma T, De Rosa G, Mayol L, Pacelli R, Pignata S, Scala S. Portella L, et al. Among authors: camerlingo r. Heliyon. 2024 Jul 31;10(15):e35524. doi: 10.1016/j.heliyon.2024.e35524. eCollection 2024 Aug 15. Heliyon. 2024. PMID: 39170328 Free PMC article.
Pharmacological inhibition of CDK4/6 impairs diffuse pleural mesothelioma 3D spheroid growth and reduces viability of cisplatin-resistant cells.
Costa A, Forte IM, Pentimalli F, Iannuzzi CA, Alfano L, Capone F, Camerlingo R, Calabrese A, von Arx C, Benot Dominguez R, Quintiliani M, De Laurentiis M, Morrione A, Giordano A. Costa A, et al. Among authors: camerlingo r. Front Oncol. 2024 Jul 1;14:1418951. doi: 10.3389/fonc.2024.1418951. eCollection 2024. Front Oncol. 2024. PMID: 39011477 Free PMC article.
The Impact of Inadequate Exposure to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors on the Development of Resistance in Non-Small-Cell Lung Cancer Cells.
Frezzetti D, Caridi V, Marra L, Camerlingo R, D'Alessio A, Russo F, Dotolo S, Rachiglio AM, Esposito Abate R, Gallo M, Maiello MR, Morabito A, Normanno N, De Luca A. Frezzetti D, et al. Among authors: camerlingo r. Int J Mol Sci. 2024 Apr 29;25(9):4844. doi: 10.3390/ijms25094844. Int J Mol Sci. 2024. PMID: 38732063 Free PMC article.
The hydrophilic extract from a new tomato genotype (named DHO) kills cancer cell lines through the modulation of the DNA damage response induced by Campthotecin treatment.
Barone D, Iannuzzi CA, Forte IM, Ragosta MC, Cuomo M, Dell'Aquila M, Altieri A, Caporaso A, Camerlingo R, Rigano MM, Monti DM, Barone A, Imbimbo P, Frusciante L, Monda M, D'Angelo M, De Laurentiis M, Giordano A, Alfano L. Barone D, et al. Among authors: camerlingo r. Front Oncol. 2023 Jun 20;13:1117262. doi: 10.3389/fonc.2023.1117262. eCollection 2023. Front Oncol. 2023. PMID: 37409248 Free PMC article.
Enhanced efficacy of formoterol-montelukast salt in relieving asthma features and in preserving β2-agonists rescue therapy.
Cerqua I, Granato E, Petti A, Pavese R, Costa SKP, Feitosa KB, Soares AG, Muscara M, Camerlingo R, Rea G, Fiorino F, Santagada V, Frecentese F, Cirino G, Caliendo G, Severino B, Roviezzo F. Cerqua I, et al. Among authors: camerlingo r. Pharmacol Res. 2022 Dec;186:106536. doi: 10.1016/j.phrs.2022.106536. Epub 2022 Nov 1. Pharmacol Res. 2022. PMID: 36332810
Correction to: HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation.
Roca MS, Moccia T, Iannelli F, Testa C, Vitagliano C, Minopoli M, Camerlingo R, De Riso G, De Cecio R, Bruzzese F, Conte M, Altucci L, Di Gennaro E, Avallone A, Leone A, Budillon A. Roca MS, et al. Among authors: camerlingo r. J Exp Clin Cancer Res. 2022 Apr 11;41(1):138. doi: 10.1186/s13046-022-02324-2. J Exp Clin Cancer Res. 2022. PMID: 35410264 Free PMC article. No abstract available.
HDAC class I inhibitor domatinostat sensitizes pancreatic cancer to chemotherapy by targeting cancer stem cell compartment via FOXM1 modulation.
Roca MS, Moccia T, Iannelli F, Testa C, Vitagliano C, Minopoli M, Camerlingo R, De Riso G, De Cecio R, Bruzzese F, Conte M, Altucci L, Di Gennaro E, Avallone A, Leone A, Budillon A. Roca MS, et al. Among authors: camerlingo r. J Exp Clin Cancer Res. 2022 Mar 3;41(1):83. doi: 10.1186/s13046-022-02295-4. J Exp Clin Cancer Res. 2022. PMID: 35241126 Free PMC article.
45 results